Conexeu Sciences is trading 6.01% lower at $3.44 after the regular-session close at $3.66. - The stock rose 17.31% during the October 6 session before reversing after hours. - Conexeu Sciences said multiple scaled-up CXU material batches met its specifications, and its planned FDA 510(k) submission remains on track for the first quarter of 2027. - The announcement was published earlier in the day; available reporting does not establish it as the cause of the after-hours decline.